Semax

SEMAX

Type: Synthetic heptapeptide (ACTH fragment analog)

Description:
Semax is a synthetic peptide analog derived from a fragment of adrenocorticotropic hormone (ACTH) and is widely studied in laboratory research involving neuropeptide signaling, cognitive pathway modeling, and central nervous system communication. It is structurally modified to enhance stability, making it useful for controlled investigations into peptide–receptor interactions within neural signaling networks.

In research and preclinical models, Semax is utilized to examine neurotransmitter regulation, synaptic signaling pathways, and gene expression modulation in neural tissues. Its well-characterized structure allows researchers to study signal transduction mechanisms, structure–activity relationships, and peptide effects on neurochemical pathways under controlled experimental conditions.

Research Areas of Interest:

• Neuropeptide and neurotransmitter signaling research

• Central nervous system pathway modeling

• Peptide–receptor interaction analysis

• Gene expression and signal transduction studies

• Structure–activity relationship (SAR) research